Trial Profile
A phase Ib multiple dose study evaluating TTP-273 in patients with type 2 diabetes not controlled on metformin
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs TTP 273 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 12 May 2016 Data from this trial were presented at the Keystone Symposia on New Therapeutics for Diabetes and Obesity 2016, according to a vTv Therapeutics LLC media release.
- 20 Apr 2016 Data will be presented at the Keystone Symposia on New Therapeutics for Diabetes and Obesity 2016, according to a vTv Therapeutics LLC media release.
- 22 Feb 2016 Results presented at the Keystone Symposia on G-Protein Coupled Receptors: Structure, Signaling and Drug Discovery 2016, according to a vTv Therapeutics LLC media release.